Price T Rowe Associates Inc Bluebird Bio, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 63,425 shares of BLUE stock, worth $551,163. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,425

Previous 54,714 15.92%

Holding current value

$551,163

Previous $54,000 38.89%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.47 - $1.35 $4,094 - $11,759	8,711 Added 15.92%	63,425 $33,000
Q1 2024 May 15, 2024	BUY	$0.91 - $1.75 $26,492 - $50,947	29,113 Added 113.72%	54,714 $71,000
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $3,175 - $11,620	2,406 Added 10.37%	25,601 $36,000
Q3 2023 Nov 14, 2023	SELL	$3.02 - $4.05 $60,756 - $81,477	-20,118 Reduced 46.45%	23,195 $71,000
Q2 2023 Aug 14, 2023	BUY	$2.79 - $5.03 $25,734 - $46,396	9,224 Added 27.06%	43,313 $143,000
Q1 2023 May 15, 2023	BUY	$3.14 - $8.22 $15,511 - $40,606	4,940 Added 16.95%	34,089 $109,000
Q4 2022 Feb 14, 2023	BUY	$5.77 - $8.49 $5,366 - $7,895	930 Added 3.3%	29,149 $202,000
Q3 2022 Nov 14, 2022	BUY	$3.75 - $7.39 $26,355 - $51,936	7,028 Added 33.17%	28,219 $179,000
Q2 2022 Aug 15, 2022	BUY	$2.94 - $5.23 $1,490 - $2,651	507 Added 2.45%	21,191 $88,000
Q1 2022 May 16, 2022	BUY	$4.07 - $10.6 $6,121 - $15,942	1,504 Added 7.84%	20,684 $100,000
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $81,303 - $147,996	-9,074 Reduced 32.12%	19,180 $192,000
Q3 2021 Nov 15, 2021	BUY	$11.24 - $21.0 $663 - $1,239	59 Added 0.21%	28,254 $540,000
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $16.7 Million - $20.4 Million	-923,645 Reduced 97.04%	28,195 $902,000
Q1 2021 May 17, 2021	SELL	$16.59 - $33.89 $1.36 Million - $2.78 Million	-81,980 Reduced 7.93%	951,840 $28.7 Million
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $28.4 Million - $39.2 Million	1,033,820 New	1,033,820 $44.7 Million

Others Institutions Holding BLUE

# of Institutions

150

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $670M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Bluebird Bio, Inc. Transaction History